These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33248114)

  • 1. Significance of nuclear LOXL2 inhibition in fibroblasts and myofibroblasts in the fibrotic process of acute respiratory distress syndrome.
    Matsuo A; Tanida R; Yanagi S; Tsubouchi H; Miura A; Shigekusa T; Matsumoto N; Nakazato M
    Eur J Pharmacol; 2021 Feb; 892():173754. PubMed ID: 33248114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway.
    Wen X; Liu Y; Bai Y; Li M; Fu Q; Zheng Y
    Int J Mol Med; 2018 Dec; 42(6):3530-3541. PubMed ID: 30320382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.
    Aumiller V; Strobel B; Romeike M; Schuler M; Stierstorfer BE; Kreuz S
    Sci Rep; 2017 Mar; 7(1):149. PubMed ID: 28273952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin attenuates pulmonary fibrosis in mice and human lung fibroblasts, by the regulation of myofibroblast differentiation and apoptosis.
    Yildirim M; Kayalar O; Atahan E; Oztay F
    J Biochem Mol Toxicol; 2022 Jul; 36(7):e23074. PubMed ID: 35416377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
    Wei Y; Kim TJ; Peng DH; Duan D; Gibbons DL; Yamauchi M; Jackson JR; Le Saux CJ; Calhoun C; Peters J; Derynck R; Backes BJ; Chapman HA
    J Clin Invest; 2017 Oct; 127(10):3675-3688. PubMed ID: 28872461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
    Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis.
    Hofmann K; Fiedler S; Vierkotten S; Weber J; Klee S; Jia J; Zwickenpflug W; Flockerzi V; Storch U; Yildirim AÖ; Gudermann T; Königshoff M; Dietrich A
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):560-568. PubMed ID: 27932059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.
    Kono Y; Nishiuma T; Nishimura Y; Kotani Y; Okada T; Nakamura S; Yokoyama M
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):395-404. PubMed ID: 17641298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
    J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
    Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis.
    Hu M; Che P; Han X; Cai GQ; Liu G; Antony V; Luckhardt T; Siegal GP; Zhou Y; Liu RM; Desai LP; O'Reilly PJ; Thannickal VJ; Ding Q
    J Pharmacol Exp Ther; 2014 Oct; 351(1):87-95. PubMed ID: 25047515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis.
    Schissel SL; Dunsmore SE; Liu X; Shine RW; Perrella MA; Layne MD
    Am J Pathol; 2009 Mar; 174(3):818-28. PubMed ID: 19179605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
    Ikenaga N; Peng ZW; Vaid KA; Liu SB; Yoshida S; Sverdlov DY; Mikels-Vigdal A; Smith V; Schuppan D; Popov YV
    Gut; 2017 Sep; 66(9):1697-1708. PubMed ID: 28073888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype.
    Kant TA; Newe M; Winter L; Hoffmann M; Kämmerer S; Klapproth E; Künzel K; Kühnel MP; Neubert L; El-Armouche A; Künzel SR
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
    Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
    Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.